Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Givaudan, Unilever target the microbiome
by Marc S. Reisch
February 12, 2018
| A version of this story appeared in
Volume 96, Issue 7
Growing interest in the skin microbiome has attracted investments by two large firms. Givaudan, a flavor and fragrance ingredient maker, has added high-throughput screening equipment at its labs in Toulouse, France, to boost development of cosmetic ingredients that protect skin microbiota. The firm acquired the Toulouse center when it bought ingredient maker Induchem in 2015. Separately, consumer products giant Unilever made its “inaugural foray” into microbiome-based products by purchasing a minority stake in the skin care start-up Gallinée.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X